Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 20 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.93 Insider Own13.59% Shs Outstand47.26M Perf Week-28.02%
Market Cap354.25M Forward P/E- EPS next Y-1.61 Insider Trans-0.63% Shs Float41.09M Perf Month-22.23%
Income-85.08M PEG- EPS next Q-0.41 Inst Own62.77% Short Float4.26% Perf Quarter-18.76%
Sales2.71M P/S130.72 EPS this Y22.74% Inst Trans-3.73% Short Ratio4.93 Perf Half Y259.90%
Book/sh2.71 P/B2.75 EPS next Y-1.94% ROA-52.52% Short Interest1.75M Perf Year177.99%
Cash/sh2.41 P/C3.09 EPS next 5Y- ROE-59.40% 52W Range1.33 - 11.76 Perf YTD4.49%
Dividend Est.- P/FCF- EPS past 5Y-63.20% ROI-64.45% 52W High-36.65% Beta1.84
Dividend TTM- Quick Ratio9.15 Sales past 5Y40.60% Gross Margin-50.72% 52W Low460.11% ATR (14)0.88
Dividend Ex-Date- Current Ratio9.15 EPS Y/Y TTM16.70% Oper. Margin-3327.44% RSI (14)30.29 Volatility17.68% 9.36%
Employees75 Debt/Eq0.03 Sales Y/Y TTM282.93% Profit Margin-3133.63% Recom1.00 Target Price15.75
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q25.07% Payout- Rel Volume0.98 Prev Close7.91
Sales Surprise265.93% EPS Surprise17.39% Sales Q/Q1856.14% EarningsMay 02 BMO Avg Volume354.40K Price7.45
SMA20-25.31% SMA50-21.33% SMA20029.10% Trades Volume347,145 Change-5.87%
Date Action Analyst Rating Change Price Target Change
Aug-31-22Initiated BTIG Research Buy $12
Jun-01-22Initiated Citigroup Buy $13
May-02-22Initiated H.C. Wainwright Buy $28
Apr-14-21Initiated Berenberg Buy $47
Jan-11-21Initiated Evercore ISI Outperform
Nov-03-20Initiated Needham Buy $34
Nov-03-20Initiated Cowen Outperform
Nov-03-20Initiated Citigroup Buy $36
May-14-24 04:15PM
May-07-24 12:00PM
May-04-24 05:31AM
May-02-24 09:58PM
08:25AM Loading…
Apr-09-24 04:05PM
Apr-01-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 04:05PM
Feb-26-24 07:00AM
Feb-14-24 05:06AM
Feb-13-24 06:00AM
Jan-08-24 07:00AM
04:05PM Loading…
Jan-04-24 04:05PM
Dec-21-23 08:00AM
Dec-13-23 10:45AM
Dec-05-23 04:15PM
Nov-14-23 09:00AM
Nov-13-23 08:52AM
Nov-09-23 11:54PM
Nov-06-23 09:28AM
Nov-02-23 09:01AM
Oct-24-23 12:30PM
Aug-10-23 05:15PM
10:14AM Loading…
Jul-06-23 10:14AM
May-25-23 05:15PM
May-09-23 05:15PM
Apr-03-23 07:00AM
Mar-21-23 11:50AM
Mar-16-23 08:31AM
Mar-01-23 07:00AM
Feb-27-23 10:46PM
Feb-23-23 04:30PM
Feb-16-23 07:00AM
Feb-09-23 06:01AM
Jan-27-23 08:34AM
Jan-09-23 07:00AM
Dec-13-22 06:51AM
Dec-01-22 09:55AM
Nov-11-22 05:51AM
Nov-08-22 04:30PM
Nov-07-22 08:00AM
Nov-04-22 11:55AM
Nov-03-22 08:30AM
Nov-01-22 04:30PM
Oct-12-22 10:04AM
Oct-05-22 04:30PM
Sep-01-22 04:15PM
Aug-20-22 08:41AM
Aug-11-22 07:00AM
Jul-06-22 07:20AM
May-28-22 08:05AM
May-13-22 08:50AM
May-12-22 07:00AM
May-06-22 09:00AM
May-05-22 09:14AM
Apr-08-22 04:55PM
Apr-05-22 05:00PM
Mar-21-22 12:00PM
Mar-15-22 07:00AM
Mar-09-22 08:21AM
Mar-02-22 08:39AM
Feb-09-22 05:00PM
Feb-02-22 01:38PM
Jan-27-22 09:21AM
Jan-05-22 08:30AM
Dec-13-21 01:57PM
Dec-03-21 07:59PM
Dec-02-21 03:40PM
Dec-01-21 10:45PM
Nov-29-21 10:30AM
Nov-28-21 07:58PM
Nov-26-21 12:39PM
Nov-25-21 11:23PM
Nov-23-21 05:44PM
Nov-22-21 01:00PM
Nov-21-21 11:20PM
Nov-18-21 04:01PM
Nov-15-21 11:32PM
Nov-11-21 05:55PM
Nov-10-21 12:30PM
Nov-09-21 01:19PM
Nov-04-21 07:00AM
Nov-03-21 05:19PM
Oct-28-21 04:30PM
Oct-12-21 11:11AM
Oct-01-21 09:56AM
Sep-01-21 04:30PM
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stout StephenSee RemarksMar 06 '24Option Exercise3.5411,10939,38085,791Mar 08 05:40 PM
Stout StephenSee RemarksMar 06 '24Sale10.5316,004168,52274,437Mar 08 05:40 PM
Neill Andrew RChief Financial OfficerJan 10 '24Sale10.0025,000250,000173,446Jan 16 04:35 PM